A federal agency yesterday calculated the price of generic drugs has declined in the past decade but remains high compared to other OECD countries. The data is the first on generic prices since the Commons rejected a proposal to negotiate a national pharmacare plan: ‘Prices have stabilized in recent years.’
This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)
